针对自身免疫性脑炎的现有和新兴疗法
Darina Dinov1, Linda Nguyen2, Kyle Blackburn1
1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Expert review of neurotherapeutics
|March 24, 2025
概括
自身免疫性脑炎 (AIE) 是一种炎症性脑部疾病,用免疫疗法治疗. 本综述审查了AIE亚型如抗NMDAR和LGI1脑炎的当前治疗方法,突出了证据差距和未来的治疗方向.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经炎症是一种神经炎症.
背景情况:
- 自身免疫性脑炎 (AIE) 是一种炎症性神经疾病,其特征是对神经或质抗原产生自身抗体.
- 目前对AIE存在免疫治疗策略,但对特定亚型的最佳治疗方案尚不清楚.
研究的目的:
- 根据自身抗体标 (细胞表面与细胞内抗原) 审查AIE的病理生理学.
- 讨论AIE目前的免疫疗法治疗方法,包括副作用管理和监测.
- 检查抗NMDAR和LGI1脑炎治疗方法的证据,并提供对未来疗法的前景.
主要方法:
- 在PubMed和谷歌学者 (2005-2024) 的文献搜索中使用关键词:"自身免疫脑炎"",反NMDA受体脑炎"",LG1脑炎".
主要成果:
- 根据自身抗体目标,AIE的病理生理学有所不同.
- 针对特定的AIE治疗方法的证据主要来自观察性研究,需要进一步的临床试验.
- 目前正在进行的临床试验和新兴的向疗法为改善患者治疗结果提供了希望.
结论:
- 免疫疗法有益于AIE患者,但对最佳策略的强有力的证据有限.
- 未来的临床试验对于建立有效的治疗指南和开发针对AIE亚型的向治疗至关重要.
相关概念视频
Electroconvulsive Therapy
20
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
20
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K


